Anbio Biotechnology Class A Ordinary Shares (NNNN) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $1.44B, listed on NASDAQ, employing roughly 27 people, carrying a beta of 4.66 to the broader market. Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. Led by Michael Lau, public since 2025-02-19.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for NNNN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →